News
-
-
-
-
-
-
PRESS RELEASE
Kuros reports 149% increase in direct MagnetOs sales and exceeds cash flow breakeven in the first nine months of 2024
Kuros Biosciences reports 149% increase in direct MagnetOs sales and surpasses cash flow breakeven in the first nine months of 2024. Company's financial highlights and future outlook highlighted -
-
-
-